RxDoctor Payments Data

Andrew McNeil, DO

Pain Medicine · Silverdale, WANPI 1356637797

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,249 of the $5,878 with a category attached, or 89.3%. It is spread thinly across 30 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations.

$5,878in general payments, 2019–2025

Across 221 payments — averaging $26.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Abbott$963
  • Nevro Corp.$610
  • AbbVie$605
  • Saluda Medical Americas, Inc.$400
  • Medtronic$344
  • plus $2K from 24 others

What the payments were for

  • Travel & lodging$62911%
  • Food & beverage$5,24989%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,878 in reported general payments places this provider in the 70th percentile of 124 pain medicine providers in Washington.

See all pain medicine providers in Washington

Medicare billing

Part B allowed, 2024
$831,345
Medicare patients
1,345
Services billed
11,114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine11$1,445
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$998
Morphine Sulfate ErMorphine Sulfate20$667
Gabapentin32$550
Hydromorphone Hcl18$358
Pregabalin28$251
Mupirocin23$180
Tizanidine Hcl26$140
Oxycodone Hcl18$120

Paid to pharmacies, not to this prescriber.

Other pain medicine in Silverdale

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →